Schizophrenia Clinical Trial
Official title:
Remote Cognitive Remediation for Psychosis
NCT number | NCT02121106 |
Other study ID # | 361958 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | September 2013 |
Est. completion date | September 2016 |
Verified date | November 2018 |
Source | Queen's University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
With medication, many individuals with psychosis experience a remission from hallucinations
and delusions, the most salient aspects of the disorders. However, alleviation of these
symptoms is not associated with recovery of everyday functioning in important areas like
working, socializing, maintaining the household, and recreational pursuits. The reason these
difficulties with functioning persist is that psychotic disorders are associated with
considerable difficulties with cognitive functions such as attention, memory, and planning.
Cognitive impairments persist even when the delusions and hallucinations are treated, and in
fact account for most of the persistent impairments in functioning.
Recently, psychological treatments called Cognitive Remediation have been developed and
tested in research settings, where techniques that train the brain to process information
more efficiently result in very large improvements in cognition. However, there are two major
hurdles remaining as investigators attempt to determine how this treatment can graduate from
research laboratories to become a widespread clinical treatment. First, cognitive remediation
in research settings is very intensive: it requires frequent visits with specialized
therapists who deliver the treatment to groups of patients. This makes it quite difficult for
people with psychosis, who might not have the financial means or motivation to travel and who
might be experiencing symptoms that make it unlikely that they will attend groups, to
participate fully if the traditional research techniques were directly transported to a
clinical setting. The second hurdle is that even though cognitive remediation improves
cognition, it does not always transfer to everyday behavior changes. Investigators recently
found that this transfer to functioning is more meaningful and durable when using additional
techniques that teach people skills such as being aware of your own thinking and to use
multiple, flexible problem solving strategies.
The goal of this project is to address these limitations by testing a new development in the
treatment: delivering cognitive remediation to participants in their homes, with cognitive
exercises and therapist support provided online. The techniques are the same as successful
in-session cognitive remediation, but those with psychosis can engage in the intervention at
home and therapists will be able to service more individuals with online discussion forums
and video demonstrations. The more people engage in cognitive remediation, the better the
outcomes. This is particularly true for receiving a consistent dose of exercise, rather than
in longer, once per week sessions typical of traditional psychotherapies. The online
component of this program provides patients with the ability to engage in a higher and more
consistent rate of exercises and skill development, and we will explore whether the amount
and continuity of engagement is associated with larger and broader improvements.
Status | Completed |
Enrollment | 100 |
Est. completion date | September 2016 |
Est. primary completion date | September 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Psychotic Disorder (e.g., schizophrenia, schizoaffective, bipolar disorder with psychotic features) Exclusion Criteria: - Current substance abuse or dependence - Physical or sensory issues that preclude completion of assessments or treatment |
Country | Name | City | State |
---|---|---|---|
Canada | Queen's University | Kingston | Ontario |
Lead Sponsor | Collaborator |
---|---|
Queen's University |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Neurocognitive composite score | 10 weeks: pre- to post-intervention | ||
Secondary | Functional Capacity | Participants will complete computerized assessments of functional skills (e.g., using a bank machine, planning medication use, scheduling appointments). | 10 weeks: at study entry (pre-treatment) and immediately following treatment (post-treatment) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |